83 related articles for article (PubMed ID: 2170226)
21. Influence of cellular DNA content on survival in ovarian carcinoma.
Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
[TBL] [Abstract][Full Text] [Related]
22. Interphase cytogenetic analysis of mucinous ovarian neoplasms.
Diebold J; Siegert S; Baretton GB; Suchy B; Meier W; Haas CJ; Löhrs U
Lab Invest; 1997 May; 76(5):661-70. PubMed ID: 9166285
[TBL] [Abstract][Full Text] [Related]
23. [DNA impulse cytophotometry measurements in head and neck tumors. Initial results of a correlation with clinical stage, therapeutic response and pattern of recurrence].
Fietkau R; Iro H; Bilek P; Sauer R
HNO; 1989 Feb; 37(2):62-6. PubMed ID: 2703374
[TBL] [Abstract][Full Text] [Related]
24. [Nuclear DNA content in squamous cell carcinoma of the tongue: prognostic significance].
Allegra E; La Mantia I; Lavina R; Palmeri S; Garozzo A
Acta Otorhinolaryngol Ital; 2000 Aug; 20(4):267-72. PubMed ID: 11234445
[TBL] [Abstract][Full Text] [Related]
25. Ki-67 immunostaining and DNA flow cytometry as prognostic factors in epithelial ovarian cancers.
Henriksen R; Strang P; Backstrom T; Wilander E; Tribukait B; Oberg K
Anticancer Res; 1994; 14(2B):603-8. PubMed ID: 8010717
[TBL] [Abstract][Full Text] [Related]
26. DNA quantification of squamous cell carcinoma of the oesophagus by flow cytometry and cytophotometric image analysis using formalin fixed paraffin embedded tissue.
Dorman AM; Walsh TN; Droogan O; Curran B; Hourihane DO; Hennessy TP; Leader M
Cytometry; 1992; 13(8):886-92. PubMed ID: 1459005
[TBL] [Abstract][Full Text] [Related]
27. Steroid hormone receptors and flow cytometric DNA ploidy in ovarian carcinoma.
Grénman SE; Klemi P; Toikkanen S; Kaihola HL; Laippala P; Mäenpää J; Mäkinen J; Grönroos M
Ann Chir Gynaecol Suppl; 1994; 208():15-9. PubMed ID: 8092763
[TBL] [Abstract][Full Text] [Related]
28. Use of DNA image cytometry in addition to flow cytometry for the study of patients with advanced ovarian cancer.
Rodenburg CJ; Ploem-Zaaijer JJ; Cornelisse CJ; Mesker WE; Hermans J; Heintz PA; Ploem JS; Fleuren GJ
Cancer Res; 1987 Aug; 47(15):3938-41. PubMed ID: 3607741
[TBL] [Abstract][Full Text] [Related]
29. [A quantitative study on nuclear DNA content and morphological parameters in ovarian cystadenocarcinoma].
Liu C; Zhao Y; Sun X
Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):738-40. PubMed ID: 8728920
[TBL] [Abstract][Full Text] [Related]
30. Ovarian tumors of low malignant potential. Correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome.
Demirel D; Laucirica R; Fishman A; Owens RG; Grey MM; Kaplan AL; Ramzy I
Cancer; 1996 Apr; 77(8):1494-500. PubMed ID: 8608534
[TBL] [Abstract][Full Text] [Related]
31. Nuclear deoxyribonucleic acid heterogeneity of ovarian borderline malignant serous tumors.
Fu YS; Ro J; Reagan JW; Hall TL; Berek J
Obstet Gynecol; 1986 Apr; 67(4):478-82. PubMed ID: 3960418
[TBL] [Abstract][Full Text] [Related]
32. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
[TBL] [Abstract][Full Text] [Related]
33. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
Lanza G; Maestri I; Dubini A; Gafà R
Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of DNA ploidy status in patients with rectal cancer.
Berczi C; Bocsi J; Bartha I; Math J; Balazs G
Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic significance of cell kinetic parameters of endometrial cancer].
Kühn W; Kaufmann M; Feichter GE; Rummel HH; Abel U; Heep J; von Minckwitz G
Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):787-92. PubMed ID: 2806852
[TBL] [Abstract][Full Text] [Related]
37. Borderline epithelial tumours of the ovary--a retrospective analysis of 31 cases.
Kane SV; Bharadwaj R; Tongaonkar HB
Indian J Cancer; 1999 Mar; 36(1):18-31. PubMed ID: 10810551
[TBL] [Abstract][Full Text] [Related]
38. Proliferating cell nuclear antigen (PCNA) and Ki-67 in epithelial ovarian tumours: correlation with DNA flow cytometric analysis.
Karaburun S; Karaveli S; Peştereli HE; Simsek T; Sargin CF
Adv Clin Path; 2001 Jan; 5(1-2):3-9. PubMed ID: 11753828
[TBL] [Abstract][Full Text] [Related]
39. Image analysis of cellular DNA content in peritoneal fluid of patients with ovarian tumors of low malignant potential and invasive epithelial ovarian cancer.
Guidozzi F; Szumel RC; Ball JH; Johnston DA; Katz RL; Kidd L
Gynecol Oncol; 1996 May; 61(2):204-9. PubMed ID: 8626133
[TBL] [Abstract][Full Text] [Related]
40. [Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy].
Mecke H; Börner-Klaussner B; Grosse G; Nadjari B; Hauptmann S
Zentralbl Gynakol; 2000; 122(5):274-9. PubMed ID: 10857214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]